Company Research Report: AMPLITUDE



Company Overview



Name


AMPLITUDE

Mission


AMPLITUDE is dedicated to developing and commercializing high-end products for orthopedic surgery, primarily for lower limb procedures, effectively addressing major pathologies affecting the hip, knee, and extremities.

Founded


The company was founded in 1997.

Key People


  • Olivier JALLABERT - Founder and President

  • Stefano DRAGO - Founding Partner, PAI Mid-Market Fund

  • Charlotte PENNEC - Legal Director

  • Daniel CAILLE - Groupe VIVALTO

  • Muriel BENEDETTO - Director of Operations

  • Bruno JUGNET - Vice-president Sales and Marketing

  • Dimitri BORCHTCH - Vice-president Finance

  • Mireille LEMERY - Vice-president Quality and Regulatory Affairs

  • Alain BARTHELEMY - Director Purchasing/Logistics

  • Aurélie TEYSSIER - Director Administrative and Finance

  • Julien EAS - Director Human Resources

  • Christian VILLOING - Director International Distributors and Customer Service

  • Marc BERNARD - Director Research and Development

  • Sophie DUCHAMP - Director Industrial and Commercial Planning


Headquarters


The company is headquartered at 11, cours Jacques Offenbach, 26000 VALENCE, France.

Number of Employees


As of June 30, 2020, AMPLITUDE had 436 employees, including 58 engineers in research and development (R&D).

Revenue


AMPLITUDE reported a revenue of 88.3 million euros for the fiscal year 2019-2020.

Known For


AMPLITUDE is recognized as a major global player in surgical technologies for orthopedic applications, particularly for lower limb surgeries. The company is known for high quality, innovation, and collaboration with surgeons to produce implants and instruments that meet diverse orthopedic surgical needs.

Products



Product Range


AMPLITUDE's product range includes various high-end solutions for orthopedic surgery, particularly focusing on:
  • Hip (cotyles, femoral stems, extensions)

  • Knee (total and unicompartmental knee prostheses)

  • Cement (standard and low viscosity)

  • Computer-assisted surgery

  • Sports medicine (tendinous or ligamentary anchorage, ligamentoplasty)


Products Offered & Key Features



Hip


  • SATURNE® II: Cotyles design for primary intention surgeries.

  • EVOK®: Femoral stem for primary intention surgeries without cement.

  • INTEGRALE®: Femoral stem for primary surgeries; revision without cement.

  • GENERIC®: Various configurations of femoral stems, both cemented and non-cemented.

  • E.T.O.I.L.E.®: Extension for the orthopedic table.


Knee


  • SCORE® II: Total knee prosthesis for primary intentions.

  • UNI SCORE®: Unicompartmental knee prosthesis.


Cement


  • AMPLIFIX® 1: Standard viscosity cement, available with Gentamicine.

  • AMPLIFIX® 3: Low viscosity cement with Gentamicine.


Computer-Assisted Surgery


  • AMPLIVISION®: A comprehensive navigation system for orthopedic procedures.


Sports Medicine


  • ACLip®: Specifically designed for ligamentoplasty procedures.

  • SUTORTHO® 0.7: Tendinous or ligamentary anchoring systems.


Recent Developments



Recent Developments in the Company


  • AMPLITUDE Academy: Continued focus on education and training in innovative surgical techniques.

  • Partnerships with educational institutions like Grenoble INP ESISAR enhance student engagement.

  • Operational and production enhancements across new facilities.


New Products Launched


  • Expansion of software solutions, including AMPLIVISION AKN V3 for better surgical navigation.

  • New training and educational programs, including the AMPLITUDE Academy and various masterclasses.


New Features Added to Existing Products


  • Enhancement in navigation systems tailored for specific surgeries.

  • Improved functionality in existing product lines as a result of scientific partnerships and advanced R&D.


New Partnerships


  • Solidified international presence with successful launches in countries like South Africa, Germany, Australia, Benelux, Brazil, and Switzerland.

  • Increased engagement with distributors across Europe, Asia, and Africa.

  • Partnerships with hospitals and surgeons for real-time feedback and product enhancements.


Conclusion



No additional commentary.